Biotechnology: 1 294 listed companies tracked by Investlytic worldwide, Health sector, for a combined capitalization of 2 117,3 B $ at 29/10/2026. The largest are Novo Nordisk A/S, Vertex Pharmaceuticals Incorporated, CSL Limited.
| # | Company | Market cap |
|---|---|---|
| 1 | Novo Nordisk A/S | 175,3 Bn $ |
| 2 | Vertex Pharmaceuticals Incorporated | 141,7 Bn $ |
| 3 | CSL Limited | 137,0 Bn $ |
| 4 | Regeneron Pharmaceuticals, Inc. | 95,5 Bn $ |
| 5 | Moderna, Inc. | 88,5 Bn $ |
| 6 | UCB S.A. | 60,0 Bn $ |
| 7 | argenx SE | 56,1 Bn $ |
| 8 | Samsung Biologics Co.,Ltd. | 51,9 Bn $ |
| 9 | Revolution Medicines, Inc. | 41,0 Bn $ |
| 10 | BeOne Medicines Ltd. Class A | 39,2 Bn $ |
| 11 | Genmab A/S | 35,9 Bn $ |
| 12 | Celltrion, Inc. | 32,8 Bn $ |
| 13 | Royalty Pharma plc | 29,9 Bn $ |
| 14 | Roivant Sciences Ltd. | 26,7 Bn $ |
| 15 | United Therapeutics Corporation | 25,7 Bn $ |
| 16 | Incyte Corporation | 24,5 Bn $ |
| 17 | WuXi Biologics (Cayman) Inc. | 23,4 Bn $ |
| 18 | BioNTech SE | 22,1 Bn $ |
| 19 | Alnylam Pharmaceuticals, Inc. | 22,1 Bn $ |
| 20 | Exelixis, Inc. | 17,4 Bn $ |
| 21 | Innovent Biologics, Inc. | 17,3 Bn $ |
| 22 | Ascendis Pharma A/S | 16,5 Bn $ |
| 23 | Halozyme Therapeutics, Inc. | 14,9 Bn $ |
| 24 | BridgeBio Pharma, Inc. | 14,6 Bn $ |
| 25 | Jazz Pharmaceuticals plc | 14,0 Bn $ |
| 26 | Summit Therapeutics Inc. | 12,8 Bn $ |
| 27 | Financière de Tubize S.A. | 11,4 Bn $ |
| 28 | Bio-Techne Corporation | 11,4 Bn $ |
| 29 | BioMarin Pharmaceutical Inc. | 11,3 Bn $ |
| 30 | ALTEOGEN Inc. | 11,0 Bn $ |
| 31 | Sino Biopharmaceutical Limited | 10,8 Bn $ |
| 32 | Kymera Therapeutics, Inc. | 10,8 Bn $ |
| 33 | Genscript Biotech Corporation | 10,1 Bn $ |
| 34 | Madrigal Pharmaceuticals, Inc. | 9,9 Bn $ |
| 35 | Krystal Biotech, Inc. | 9,8 Bn $ |
| 36 | Vaxcyte, Inc. | 9,8 Bn $ |
| 37 | Caris Life Sciences, Inc. | 9,7 Bn $ |
| 38 | Akeso, Inc. | 9,6 Bn $ |
| 39 | Haisco Pharmaceutical Group Co., Ltd. | 9,4 Bn $ |
| 40 | Pharmaron Beijing Co., Ltd. | 9,4 Bn $ |
| 41 | Protagonist Therapeutics, Inc. | 9,4 Bn $ |
| 42 | TG Therapeutics, Inc. | 9,4 Bn $ |
| 43 | Spyre Therapeutics, Inc. | 8,9 Bn $ |
| 44 | ImmunityBio, Inc. | 8,8 Bn $ |
| 45 | Corcept Therapeutics Incorporated | 8,8 Bn $ |
| 46 | Cytokinetics, Incorporated | 8,8 Bn $ |
| 47 | Arrowhead Pharmaceuticals, Inc. | 8,5 Bn $ |
| 48 | ALK-Abelló A/S | 8,2 Bn $ |
| 49 | Praxis Precision Medicines, Inc. | 8,0 Bn $ |
| 50 | Abivax S.A. | 7,7 Bn $ |
Capitalizations in dollars at 29/10/2026 (closing price, Investlytic rankings). A company listed on several exchanges only appears once.
Entities related to Biotechnologies on Investlytic, with the source and date of each link.
Sources: Listed company profiles (Financial Modeling Prep), 01/11/2026 data
Sources: Listed company profiles (Financial Modeling Prep), 01/11/2026 data
English
Français
Español